Dr Mark Watson is Head of Programmes at Clinical Research Development Ireland(CRDI; formerly Molecular Medicine Ireland), an Investigator in CÚRAM, the SFI Centre for Research in Medical Devices, and a Co-Director of the Wellcome - HRB Irish Clinical Academic Training programme.
Clinical Research Development Ireland is a not-for-profit partnership of Trinity College Dublin, NUI Galway, University College Dublin, the Royal College of Surgeons in Ireland and University College Cork, with the objective of accelerating the translation of biomedical research into improved diagnostics, therapies and devices for patients. CRDI develops and supports collaborations that are building the infrastructures and environment for translational/clinical research and precision medicine.
Mark Watson joined the forerunner of CRDI and MMI, the Dublin Molecular Medicine Centre, in 2003. In the ensuing years, Mark and his team have worked with the partners to win funding for, develop and deliver widely-available short courses, innovative structured PhD programmes and shared resources to support translational and clinical research. He was acting Chief Executive of MMI